Patent Assignment
Reel/Frame 053560/0152
Release of Security Interest
Recorded: 2020-08-20
Pages: 39
Assignor
MANCHESTER SECURITIES CORP.
Executed: 2019-09-05
Assignee
CORMEDIX INC.
400 CONNELL DRIVE, SUITE 5000, BERKELEY HEIGHTS, NEW JERSEY, 07922
Covered Properties
(45)
Skin-Penetrating Formulation of Taurolidine
PCT:
PCT/US2017/068956 ↗
Antimicrobial Compositions, Including Antimicrobial Hydrogels, Effective Against Mature Biofilms
PCT:
PCT/US2018/012192 ↗
Antimicrobial Delivery System for the Prevention and Treatment of Infections in the Colon
PCT:
PCT/US2018/012211 ↗
Use of an Injectable Antimicrobial Composition for the Prevention and/or Treatment of Osteoarthritis
PCT:
PCT/US2018/023844 ↗
Antimicrobial Locks Comprising Taurinamide Derivatives and Carboxylic Acids and/or Salts Thereof
Patent:
6,166,007 →
Application:
09/307,916 →
Biocidal locks
Patent:
6,350,251 →
Application:
09/483,966 →
Antimicrobial Locks Comprising Taurinamide Derivatives and Carboxylic Acids and/or Salts Thereof
Patent:
6,569,852 →
Application:
09/552,198 →
Method and Apparatus for Overcoming Infection in a Tissue Pocket Surrounding an Implanted Device
Patent:
6,451,003 →
Application:
09/640,292 →
Antimicrobial Locks Comprising Taurinamide Derivatives and Carboxylic Acids and/or Salts Thereof
Coatings and Soaks for Medical Prosthetic Devices Comprising Taurinamide Derivatives and Carboxylic Acids and/or Salts Thereof
Method and Apparatus for Overcoming Infection in a Tissue Pocket Surrounding an Implanted Device
Peritoneal Dialysis Solution with Taurolidine
Antimicrobial Locking Solutions Comprising Taurinamide Derivatives and Biologically Acceptable Salts and Acids, with the Addition of Small Concentrations of Heparin
Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
Application:
12/661,183 →
Publication:
US 2010/0331277
Antimicrobial Locking Solutions Comprising Taurinamide Derivatives and Biologically Acceptable Salts and Acids, with the Addition of Small Concentrations of Heparin
Antimicrobial Locking Solutions Comprising Taurinamide Derivatives and Biologically Acceptable Salts and Acids, with the Addition of Small Concentrations of Heparin
Antimicrobial Locking Solutions Comprising Taurinamide Derivatives and Biologically Acceptable Salts and Acids, with the Addition of Small Concentrations of Heparin
Application:
15/156,772 →
Publication:
US 2017/0128629
Antimicrobial Wound Closure Materials, Including Antimicrobial Sutures, and Method for Closing a Wound Using the Same
Compositions for the Treatment of Joints
Application:
15/252,990 →
Publication:
US 2017/0056561
Delivery of Active Agents Using Nanofiber Webs
Application:
15/253,176 →
Publication:
US 2017/0056333
Skin-Penetrating Formulation of Taurolidine
Application:
15/287,822 →
Publication:
US 2017/0100407
Therapeutic Nanoparticles for the Treatment of Neuroblastoma and Other Cancers
Application:
15/403,876 →
Publication:
US 2017/0196875
Field Sterilizer and Vascular Connector Kit
Skin-Penetrating Formulation of Taurolidine
Application:
15/858,228 →
Publication:
US 2018/0117058
Antimicrobial Compositions, Including Antimicrobial Hydrogels, Effective Against Mature Biofilms
Antimicrobial Delivery System for the Prevention and Treatment of Infections in the Colon
Application:
15/861,248 →
Publication:
US 2018/0185378
Antimicrobial Locking Solutions Comprising Taurinamide Derivatives and Biologically Acceptable Salts and Acids, with the Addition of Small Concentrations of Heparin
Application:
15/911,527 →
Publication:
US 2019/0038813
Use of an Injectable Antimicrobial Composition for the Prevention and/or Treatment of Osteoarthritis
Application:
15/928,988 →
Publication:
US 2018/0207103
Antimicrobial Wound Closure Materials, Including Antimicrobial Sutures
Application:
62/206,368 →
Intra-Articular Formulation of Taurolidine
Application:
62/211,904 →
Antimicrobial Compositions and Methods Using Nanofiber Webs
Application:
62/211,912 →
Antimicrobial Compositions for Treatment of Joints
Application:
62/211,922 →
Skin-Penetrating Formulation of Taurolidine
Application:
62/238,167 →
Nanoparticle System for the Treatment of Neuroblastoma
Application:
62/277,243 →
Antimicrobial Wound Closure Materials, Including Antimicrobial Sutures
Application:
62/292,597 →
Field Sterilizer and Iv Connector Kit
Application:
62/313,848 →
Skin-Penetrating Formulation of Taurolidine
Application:
62/440,054 →
Antimicrobial Compositions, Including Antimicrobial Hydrogels, Effective Against Mature Biofilms
Application:
62/442,775 →
Antimicrobial Delivery System for the Prevention and Treatment of Infections in the Colon
Application:
62/442,778 →
Use of Injectable Antimicrobial for the Prevention and/or Treatment of Osteoarthritis
Application:
62/474,695 →
Methods and Pharmaceutical Compositions for Treating Candida Auris in Blood
Application:
62/608,843 →
Pharmaceutical Compositions and Methods for Treating Keloids, Hypertrophic Scars and Wounds
Application:
62/608,890 →
Methods and Compositions for Treating Neuroblastoma in a Juvenile Mammalian Body
Application:
62/723,592 →
Neuroblastoma Treatment with Taurolidine Hydrolysis Products
Application:
62/723,618 →
Taurolidine Treatment for Myc-Expressing Tumors in Mammalian Bodies
Application:
62/725,650 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 4, 1999
From: SODEMANN, KLAUS
To: BIOLINK CORPORATION
Reel/Frame 009998/0132 →
Assignment of Assignor's Interest
Jun 1, 2000
From: PROL, FRANK R.; ESTABROOK, BRIAN K.; SODEMANN, KLAUS
To: BIOLINK CORPORATION
Reel/Frame 010869/0118 →
Assignment of Assignor's Interest
Aug 30, 2000
From: PROSL, FRANK R.; POLASCHEGG, HANS-DIETRICH; ESTABROOK,BRIAN K.; SODEMANN,KLAUS
To: BIOLINK CORPORATION
Reel/Frame 011169/0680 →
Security Interest
Oct 19, 2001
From: BIOLINK CORPORATION
To: MCKINLAY, THOMAS, AS COLLATERAL AGENT
Reel/Frame 012075/0975 →
Assignment of Assignor's Interest
Aug 2, 2002
From: POLASCHEGG, HANS-DIETRICH
To: BIOLINK CORPORATION
Reel/Frame 013152/0899 →
Termination of Security Interest
Feb 13, 2003
From: MCKINLEY, THOMAS
To: BIOLINK CORPORATION
Reel/Frame 013417/0937 →
Patent Collateral Assignment and Security Agreement
Feb 27, 2003
From: BIOLINK CORPORATION
To: SPINNAKER CAPITAL LLC, AS AGENT
Reel/Frame 013791/0714 →
Assignment of Assignor's Interest
Oct 27, 2004
From: MADOFF, DAVID B., DULY APPOINTED TRUSTEE IN BANKRUPTCY FOR THE DEBTOR BIOLINK CORPORATION IN CASE NO. 03-17076 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF MASSACHUSETTS, EASTERN DIVISION, HAVING ACQUIRED TITLE THERETO PURSUANT TO UNITED STATES BANKRUPTCY CODE S 541
To: ND PARTNERS, LLC
Reel/Frame 015293/0303 →
Assignment of Assignor's Interest
Oct 27, 2004
From: MADOFF, DAVID B., DULY APPOINTED TRUSTEE IN BANKRUPTCY FOR THE DEBTOR BIOLINK CORPORATION IN CASE NO. 03-17076 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF MASSACHUSETTS, EASTERN DIVISION, HAVING ACQUIRED TITLE THERETO PURSUANT TO UNITED STATES BANKRUPTCY CODE S 541
To: ND PARTNERS, LLC
Reel/Frame 015293/0301 →
Assignment of Assignor's Interest
Oct 27, 2004
From: MADOFF, DAVID B. DULY APPOINTED TRUSTEE IN BANKRUPTCY FOR THE DEBTOR BIOLINK CORPORATION IN CASE NO. 03-17076 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF MASSACHUSETTS, EASTERN DIVISION, HAVING ACQUIRED TITLE THERETO PURSUANT TO UNITED STATES BANKRUPTCY CODE # 541
To: ND PARTNERS, LLC
Reel/Frame 015293/0460 →
Assignment of Assignor's Interest
Oct 27, 2004
From: MADOFF, DAVID B., DULY APPOINTED TRUSTEE IN BANKRUPTCY FOR THE DEBTOR BIOLINK CORPORATION IN CASE NO. 03-17076 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF MASSACHUSETTS, EASTERN DIVISION, HAVING ACQUIRED TITLE THERETO PURSUANT TO UNITED STATES BANKRUPTCY CODE $ 541
To: ND PARTNERS, LLC
Reel/Frame 015293/0764 →
Assignment of Assignor's Interest
Oct 27, 2004
From: MADOFF, DAVID B.
To: ND PARTNERS, LLC
Reel/Frame 015302/0105 →
Assignment of Assignor's Interest
Oct 27, 2004
From: MADOFF, DAVID B., DULY APPOINTED TRUSTEE IN BANKRUPTCY FOR THE DEBTOR BIOLINK CORPORATION IN CASE NO. 03-17076 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF MASSACHUSETTS, EASTERN DIVISION, HAVING ACQUIRED TITLE THERETO PURSUANT TO UNITED STATES BANKRUPTCY CODE $ 541
To: ND PARTNERS, LLC
Reel/Frame 015312/0840 →
Assignment of Assignor's Interest
Oct 27, 2004
From: DAVID B. MADOFF, DULY APPOINTED TRUSTEE IN BANKRUPTCY FOR THE DEBTOR BIOLINK CORPORATION IN CASE NO. 03-17076 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF MASSACHUSETTS, EASTERN DIVISION, HAVING ACQUIRED TITLE THERETO PURSUANT TO UNITED STATES BANKRUPTCY CODE 541
To: ND PARTNERS, LLC
Reel/Frame 015334/0526 →
Assignment of Assignor's Interest
Oct 28, 2004
From: MADOFF, DAVID B.
To: ND PARTNERS, LLC
Reel/Frame 015302/0058 →
Assignment of Assignor's Interest
Nov 15, 2004
From: PROSL, FRANK R.
To: ND PARTNERS, LLC
Reel/Frame 015376/0520 →
Security Agreement
May 31, 2013
From: CORMEDIX INC.
To: KINGSBROOK OPPORTUNITIES MASTER FUND LP; MANCHESTER SECURITIES CORP.
Reel/Frame 030520/0504 →
Assignment of Assignor's Interest
Apr 5, 2017
From: MILBY, RANDY
To: CORMEDIX INC.
Reel/Frame 041855/0982 →
Assignment of Assignor's Interest
Apr 5, 2017
From: DILUCCIO, ROBERT; REIDENBERG, BRUCE
To: CORMEDIX INC.
Reel/Frame 041856/0481 →
Assignment of Assignor's Interest
Apr 5, 2017
From: REIDENBERG, BRUCE; DILUCCIO, ROBERT
To: CORMEDIX INC.
Reel/Frame 041856/0625 →
Assignment of Assignor's Interest
Apr 5, 2017
From: DILUCCIO, ROBERT; LORENC, Z. PAUL
To: CORMEDIX INC.
Reel/Frame 041856/0829 →
Assignment of Assignor's Interest
Apr 5, 2017
From: MILBY, RANDY
To: CORMEDIX INC.
Reel/Frame 041857/0024 →
Assignment of Assignor's Interest
Apr 5, 2017
From: DILUCCIO, ROBERT; MILBY, RANDY
To: CORMEDIX INC.
Reel/Frame 041857/0186 →
Assignment of Assignor's Interest
Apr 5, 2017
From: DILUCCIO, ROBERT
To: CORMEDIX INC.
Reel/Frame 041858/0933 →
Assignment of Assignor's Interest
Nov 14, 2018
From: REIDENBERG, BRUCE
To: CORMEDIX INC.
Reel/Frame 047504/0569 →